D, Smith G, Warwick M (2001). "Preclinical and clinical pharmacology of Rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase crestor 20 mg Am crestor 20 mg Cardiol 87 (5A): 28B-32B. PMID 11256847.[edit] External linksCrestor web site, by AstraZenecaRosuvastatin (Crestor) Information.

without the supervision of a physician.^ a b Core Data Sheet, Crestor Tablets (PDF). AstraZeneca PLC (2005).Annual Report and Form 20-F, 2003 (PDF). AstraZeneca PLC (June 17 2003). Retrieved on 2005-03-20.McTaggart F, Buckett L, crestor 20 mg R, Holdgate G, McCormick A, Schneck D, Smith G, Warwick M crestor 20 mg "Preclinical and clinical pharmacology of Rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.". Am J Cardiol 87 (5A): 28B-32B. PMID 11256847.[edit] External linksCrestor web site, by AstraZenecaRosuvastatin (Crestor) Information. eMedicineHealth (10/16/2005).[hide]v • d • eLipid modifying agents (C10)Statins Atorvastatin • Cerivastatin‡ • Fluvastatin • Lovastatin • Mevastatin crestor 20 mg Pitavastatin crestor 20 mg Pravastatin • Rosuvastatin • SimvastatinFibrates Clofibrate‡ • Bezafibrate • Aluminium crestor 20 mg • Gemfibrozil • Fenofibrate • Simfibrate • Ronifibrate • crestor 20 mg • Etofibrate • ClofibrideBile acid sequestrants Colestyramine • crestor 20 mg • Colextran • ColesevelamNiacin.

the date reflects the last revision date.[edit] ReferencesAnnual Report and Form 20-F, 2003 (PDF). AstraZeneca.